GOLSEEK-1: A PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF GOLCADOMIDE PLUS R-CHOP VS R-CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED, HIGH-RISK, LARGE B-CELL LYMPHOMA
EHA Library, Theodoros Vassilakopoulos,
421842
EFFICACY AND SAFETY OF A NOVEL ANTI-CD20 AGENT “RIPERTAMAB (SCT400)” -BASED CHEMOTHERAPY IN PATIENTS WITH CD20-POSITIVE B-NHL: A MULTI-CENTER, RETROSPECTIVE, REAL-WORLD STUDY IN CHINA
EHA Library, Jun Li,
421883